COYA vs. XBI
Compare and contrast key facts about Coya Therapeutics Inc. (COYA) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: COYA or XBI.
Correlation
The correlation between COYA and XBI is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
COYA vs. XBI - Performance Comparison
Key characteristics
COYA:
-0.04
XBI:
0.13
COYA:
0.49
XBI:
0.35
COYA:
1.06
XBI:
1.04
COYA:
-0.05
XBI:
0.06
COYA:
-0.09
XBI:
0.34
COYA:
31.76%
XBI:
9.32%
COYA:
73.89%
XBI:
24.48%
COYA:
-52.47%
XBI:
-63.89%
COYA:
-33.27%
XBI:
-47.36%
Returns By Period
In the year-to-date period, COYA achieves a 18.67% return, which is significantly higher than XBI's 1.50% return.
COYA
18.67%
26.39%
32.81%
-9.57%
N/A
N/A
XBI
1.50%
3.91%
-6.49%
-1.73%
-1.23%
2.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
COYA vs. XBI — Risk-Adjusted Performance Rank
COYA
XBI
COYA vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Coya Therapeutics Inc. (COYA) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
COYA vs. XBI - Dividend Comparison
COYA has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.15%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COYA Coya Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.15% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
COYA vs. XBI - Drawdown Comparison
The maximum COYA drawdown since its inception was -52.47%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for COYA and XBI. For additional features, visit the drawdowns tool.
Volatility
COYA vs. XBI - Volatility Comparison
Coya Therapeutics Inc. (COYA) has a higher volatility of 13.74% compared to SPDR S&P Biotech ETF (XBI) at 6.22%. This indicates that COYA's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.